ArticleEuropean geriatric medicine2026
Sarcopenic obesity defined by the Asia-Oceania consensus and its association with activities of daily living in post-stroke patients: a retrospective cohort study.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeA consensus on the definition of sarcopenic obesity (SO) is lacking, and its clinical significance in post-stroke rehabilitation remains unclear. This study aimed to investigate the prevalence of SO using the new Asia-Oceania consensus criteria in post-stroke patients and compare its association with functional outcomes against existing definitions.
methodsThis retrospective cohort study was conducted in post-stroke patients aged ≥ 40 years at a single post-acute rehabilitation ward in Japan. SO was diagnosed according to the Asia-Oceania, JWGSO, and ESPEN/EASO criteria. The primary outcome was the Functional Independence Measure (FIM) motor score at discharge. Secondary outcome is home discharge. Multivariate regression models were used to assess the association between SO and outcomes.
resultsA total of 512 post-stroke patients (mean age: 74.1 years, 53.9% men) were included in the final analysis. The prevalence of SO defined by the Asia-Oceania consensus was 3.3%, lower than that of the JWGSO (7.4%) and ESPEN/EASO (10.0%) criteria, with variable agreement between definitions (Cohen's κ: 0.474-0.816). In the fully adjusted multivariate models, SO, regardless of the definition used, was not significantly associated with FIM motor score, or discharge to home.
conclusionsThe prevalence of SO in this cohort varied substantially by definition, and the new Asia-Oceania consensus definition was not an independent predictor of functional outcomes. Our findings suggest that in this clinical setting, the robust identification of sarcopenia itself may hold greater clinical importance than the composite diagnosis of sarcopenic obesity.
Indexed as
Identifiers
41699352What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.